Harnessing nucleic acid-based therapeutics for atherosclerotic cardiovascular disease: state of the art.
Sign Up to like & getrecommendations! Published in 2019 at "Drug discovery today"
DOI: 10.1016/j.drudis.2019.04.007
Abstract: Dyslipidemia is one of the major but modifiable risk factors for atherosclerotic cardiovascular disease (ACVD). Despite the accessibility of statins and other lipid-lowering drugs, the burden of ACVD is still high globally, highlighting the need… read more here.
Keywords: atherosclerotic cardiovascular; acid based; harnessing nucleic; cardiovascular disease ... See more keywords